Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.50 TWD
287.06 M TWD
3.19 B TWD
252.82 M
About SCINOPHARM TAIWAN LTD
Sector
Industry
CEO
Li An Lu
Website
Headquarters
Tainan
Founded
1997
ISIN
TW0001789006
FIGI
BBG0017XSN24
ScinoPharm Taiwan Ltd. engages in the research, development, manufacturing, and sales of active pharmaceutical ingredients and injections. It also provides consulting and biotechnology services.It operates through the following segments: ScinoPharm Taiwan, Ltd., SciAnda (Changshu) Pharmaceuticals Ltd., and Others. The company's products include abiraterone acetate, anastrozole, apixaban, apremilast, atazanavir sulfate, azacitidine, benazepril hydrochloride, bortezomib, capecitabine, celecoxib, cladribine, dantrolene sodium, decitabine, desmopressin acetate, docetaxel anhydrous, docetaxel trihydrate, entecavir, enzalutamide, exemestane, flumazenil, fulvestrant, galantamine, gefitinib, gemcitabine hydrochloride, ondansetron hydrochloride, and paclitaxel. The company was founded on November 11, 1997 and is headquartered in Tainan, Taiwan.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 1789 is 21.60 TWD — it has decreased by −1.14% in the past 24 hours. Watch SCINOPHARM TAIWAN LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TWSE exchange SCINOPHARM TAIWAN LTD stocks are traded under the ticker 1789.
1789 stock has fallen by −4.85% compared to the previous week, the month change is a −8.28% fall, over the last year SCINOPHARM TAIWAN LTD has showed a −17.71% decrease.
We've gathered analysts' opinions on SCINOPHARM TAIWAN LTD future price: according to them, 1789 price has a max estimate of 24.00 TWD and a min estimate of 24.00 TWD. Watch 1789 chart and read a more detailed SCINOPHARM TAIWAN LTD stock forecast: see what analysts think of SCINOPHARM TAIWAN LTD and suggest that you do with its stocks.
1789 reached its all-time high on Oct 31, 2013 with the price of 86.75 TWD, and its all-time low was 21.70 TWD and was reached on Oct 26, 2018. View more price dynamics on 1789 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
1789 stock is 2.80% volatile and has beta coefficient of 0.33. Track SCINOPHARM TAIWAN LTD stock price on the chart and check out the list of the most volatile stocks — is SCINOPHARM TAIWAN LTD there?
Today SCINOPHARM TAIWAN LTD has the market capitalization of 17.08 B, it has decreased by −5.19% over the last week.
Yes, you can track SCINOPHARM TAIWAN LTD financials in yearly and quarterly reports right on TradingView.
SCINOPHARM TAIWAN LTD is going to release the next earnings report on Apr 8, 2025. Keep track of upcoming events with our Earnings Calendar.
1789 earnings for the last quarter are 0.04 TWD per share, whereas the estimation was 0.08 TWD resulting in a −50.00% surprise. The estimated earnings for the next quarter are 0.03 TWD per share. See more details about SCINOPHARM TAIWAN LTD earnings.
SCINOPHARM TAIWAN LTD revenue for the last quarter amounts to 724.00 M TWD, despite the estimated figure of 740.00 M TWD. In the next quarter, revenue is expected to reach 662.00 M TWD.
1789 net income for the last quarter is 27.10 M TWD, while the quarter before that showed 74.88 M TWD of net income which accounts for −63.81% change. Track more SCINOPHARM TAIWAN LTD financial stats to get the full picture.
Yes, 1789 dividends are paid annually. The last dividend per share was 0.30 TWD. As of today, Dividend Yield (TTM)% is 1.39%. Tracking SCINOPHARM TAIWAN LTD dividends might help you take more informed decisions.
SCINOPHARM TAIWAN LTD dividend yield was 1.14% in 2023, and payout ratio reached 82.64%. The year before the numbers were 1.41% and 80.59% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SCINOPHARM TAIWAN LTD EBITDA is 928.45 M TWD, and current EBITDA margin is 24.35%. See more stats in SCINOPHARM TAIWAN LTD financial statements.
Like other stocks, 1789 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SCINOPHARM TAIWAN LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SCINOPHARM TAIWAN LTD technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SCINOPHARM TAIWAN LTD stock shows the strong sell signal. See more of SCINOPHARM TAIWAN LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.